Article

reviewtimes.com on 2018-12-03 14:43

GlaxoSmithKline to spend $5.1B on cancer drugmaker Tesaro

Waltham

Emma Walmsley

Related news

GlaxoSmithKline to spend $5.1B on cancer drugmaker Tesaro reviewtimes.com
Waltham
GlaxoSmithKline to spend $5.1B on cancer drugmaker Tesaro - Mon, 03 Dec 2018 PST The Spokesman-Review
Waltham , China , Shanghai
Waltham's Tesaro to be acquired by GlaxoSmithKline for $5.1B bizjournals.com
Waltham
NGSK buying cancer drugmaker Tesaro in $5.1 billion deal nypost.com
United Kingdom
GlaxoSmithKline acquiring Tesaro for $5.1B bizjournals.com
GlaxoSmithKline to Acquire Tesaro for $4.16 Billion wsj.com
Latest drug by Waltham drugmaker Tesaro rejected by FDA bizjournals.com
Waltham
GSK Buys Tesaro For $5 Billion In Dramatic Bet On Cancer Genetics Forbes
Clovis
WGSK acquiring oncology firm Tesaro in $5.1B deal, sells health drinks for $3.7B wraltechwire.com
Zebulon , Bangladesh , India
Drugmaker AbbVie to spend over $10 billion on ImmunoGen to juice its cancer-fighting treatment portfolio pressherald.com
North Chicago , Massachusetts , Waltham
MGlaxoSmithKline stops Feladilimab cancer trials marketwatch.com
Phase 2
Waltham biotech Tesaro gains $1.8B in value after ovarian cancer drug trial win bizjournals.com
Waltham
Waltham's Tesaro just got one step closer to winning FDA approval for its ovarian cancer drug bizjournals.com
Waltham
Drugmaker GSK buys US cancer firm for $1.9 billion timesofmalta.com
Malta
GSK/TESARO BrandVoice: Beyond The Clinic: The Commonality Between Living With Ovarian Cancer And Working As The Researcher Behind A Treatment Forbes
Watampone , Minneapolis , Massachusetts
Sterling slump helps profits soar at GlaxoSmithKline expressandstar.com
GlaxoSmithKline names insider Emma Walmsley as its new CEO timesofmalta.com
Switzerland , China , United Kingdom
GlaxoSmithKline snaps up 10% stake in Covid-19 drugmaker bizjournals.com